Nutrition intervention for advanced stages of diabetic kidney disease

Diabetes Spectrum

Volumn 28, Issue 3, 2015, Pages 181-186

  Goldstein Fuchs, Jordi ^a   Kalantar Zadeh, Kamyar ^b  

^a Sierra Nevada Nephrology Consultants   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FAT;

ARTICLE; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; EATING HABIT; END STAGE RENAL DISEASE; GLYCEMIC CONTROL; HUMAN; NUTRIENT; NUTRITIONAL SUPPORT; PROTEIN INTAKE; SODIUM RESTRICTION;

EID: 84964089147     PISSN: 10409165     EISSN: 19447353     Source Type: Journal    
DOI: 10.2337/diaspect.28.3.181     Document Type: Article

References (53)

1. Evert A, Boucher J, Cypress, M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014;37(Suppl. 1):S120-S143
2. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49(Suppl. 2):S12-S154
3. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
4. Kidney Disease Improving Global Outcomes (KDIGO) CKD Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-150
5. Sacks FM, Obarzanek E, Windhauser MM, et al. Rationale and design of the Dietary Approaches to Stop Hypertension (DASH) trial: a multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol 1005;5:108-118
6. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-1290
7. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol 2011;301:F919-F931
8. Tuttle K, Bakris G, Rudolf B, et al. Diabetic kidney disease: a report from an ADA consensus conference. Am J Kidney Dis 2014;64:510-533
9. Goldstein-Fuchs DJ, LaPierre AF. Nutrition and kidney disease. In Primer on Kidney Diseases, 6th ed. Philadelphia, Pa., Elsevier, 2014, p. 467-475
10. Wrone EM, Carnethon MR, Palaniappan L, Fortmann SP. Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;4:580-587
11. Hoogeveen EK, Kostense PJ, Jager A, et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998;54:203-209
12. Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003;138:460-467
13. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010;122:876-883
14. Cirillo M, Lombardi C, Chiricone D, De Santo NG, Zanchetti A, Bilancio G. Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data. Nephrol Dial Transplant 2014;21:1733-1740
15. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324:78-84
16. Hansen HP, Tauber-Lassen E, Jensen BR, Parving H-H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002;62:220-228
17. Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:660-666
18. Meloni C, Morosetti M, Suraci C, et al. Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? J Ren Nutr 2002;12:96-101
19. Pijls, LT, De Vries, H, Van Eiijk JT, Donker AJ. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr 2002;56:1200-1207
20. Dussol B, Oovanna C, Raccah D, et al. A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr 2005;15:398-406
21. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996;124:627-632
22. Robertson L, Waught N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2007; CD002181
23. Klausen A, Jensen BR, Parving HH. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney Int 1999;55:621-628
24. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998;31:954-961
25. Raal FJ, Kalk WJ, Lawon M, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6 mo prospective study. Am J Clin Nutr 1994;160:579-585
26. Dullart RP, Beusekamp JB, Meijer S, Van Doormaal JJ, Sluiter WR. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993;16:484-492
27. Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM. The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol 2014;40:582-591
28. Azadbakht L, Ahmad E. Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Renal Nutr 2009;19:479-486
29. Filipowicz R, Beddu S. Optimal nutrition for predialysis chronic kidney disease. Adv Chronic Kidney Dis 2013;2:175-180
30. Kim M, Yunsook L. Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage. Mediators Inflamm 2013;2013:510212
31. Michas G, Micha R, Zampelas A. Dietary fats and cardiovascular disease: putting together the pieces of a complicated puzzle. Atherosclerosis 2014;234:320-328
32. Covas M-I. Olive oil and the cardiovascular system. J Ital Pharmacol Soc 2007;55:175-186
33. Breslow JL. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 2006;83(Suppl. 6):1477S-1482S
34. Jump DB, Depner CM, Tripath S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res 2012;53:2525-2545
35. Shapiro H, Theilla M, Attal-Singer J, Singer P. Effects of polyunsaturated fatty acid composition in diabetic nephropathy. Nat Rev Nephrol 2011;7:110-121
36. Lee CC, Sharp SJ, Wexler DJ, Adler AI. Dietary intake of eicosapentaenoic acid and docosahexaenoic acid and diabetic nephropathy: cohort analysis of the diabetes control and complications trial. Diabetes Care 2010;33:1454-1456
37. Wright J, Cavanaugh K. Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial 2010;23:415-421
38. Kovesdy CP, Sharma K, Kalantar-Zadeh K. Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis 2008;52:766-777
39. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 2006;26:118-133
40. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808
41. Kalantar-Zadeh K. What is so bad about reverse epidemiology anyway? Semin Dial 2007;20:593-601
42. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 2005;15:142-147
43. Kalantar-Zadeh K, Anker SD, Coats AJS, Horwich TB, Fonarow GC. Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med 2005;165:1797; author reply 1797-1798
44. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY. Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 2005;23:57-63
45. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th Annual Fall Conference and Scientific Sessions. Hypertension 2005;45:811-817
46. Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K. Association of secondary hyperparathyroidism with CKD progression, health care costs, and survival in diabetic predialysis CKD patients. Nephron Clin Pract 2009;113:c54-c61
47. Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar-Zadeh K. Updates on the management of diabetes in dialysis patients. Semin Dial 2014;27:135-145
48. Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diabetes Rep 2012;12:432-439
49. Kalantar-Zadeh K, Derose SF, Nicholas S, Benner D, Sharma K, Kovesdy CP. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr 2009;19:33-37
50. Ricks J, Molnar MZ, Kovesdy CP, et al. Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes 2012;61:708-715
51. Sarno G, Mehta RJ, Guardado-Mendoza R, Jimenez-Ceja LM, De Rosa P, Muscogiuri G. New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation. Curr Diabetes Rev 2013;9:78-85
52. Chakkera HA, Mandarino LJ. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation 2013;95:647-652
53. Chakkera HA, Weil EJ, Pham P-T, Pomeroy J, Knowler WC. Can new-onset diabetes after kidney transplant be prevented? Diabetes Care 2013;36:1406-1412